市場調査レポート

商品コード

1619040

ウイルスクリアランスの市場規模、シェア、成長分析、タイプ別、用途別、エンドユーザー別、方法別、地域別 - 産業予測、2024～2031年

Viral Clearance Market Size, Share, Growth Analysis, By Type, By Application, By End User, By Method, By Region - Industry Forecast 2024-2031

出版日: 2024年12月19日
発行: SkyQuest
ページ情報: 英文 260 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ウイルスクリアランスの世界市場規模は2022年に4,929億米ドルと評価され、2023年の5,722億6,000万米ドルから2031年には1兆8,890億7,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは16.1%で成長する見通しです。

ウイルスクリアランスの市場は、モノクローナル抗体、組換えタンパク質、糖タンパク質、その他の生物製剤を製造する際に、ウイルス粒子やTSE病原体を除去する必要性が不可欠であることから、牽引力を増しています。これらの製品は、ウイルス、細菌、真菌を含む様々な汚染物質によるリスクに直面しているため、強固なウイルス安全対策が不可欠となっています。さらに、ワクチンやバイオ治療薬に対する需要の高まりとともに、製薬・バイオテクノロジー分野への投資が増加していることも、同市場の成長を後押ししています。メーカーが製品の完全性と安全性を確保するためにウイルスクリアランスを優先する中、ウイルスクリアランスプロセスの全体的な状況は、バイオプロセスにおけるコンプライアンスと有効性への重要な焦点を強調しながら、今後数年で大きく進化すると予想されます。

市場概要
ウイルス除去方法
- クロマトグラフィー
- 濾過
- 降水量
ウイルス不活化法
- Phの変更
- 溶剤洗剤（S/D）
- 殺菌
- 乾熱
- その他
ウイルス検出方法
- 次世代シーケンシング（NGS）
- ポリメラーゼ連鎖反応（PCR）
- 生体内アッセイ
- インビトロアッセイ

ウイルスクリアランス市場規模：用途別 & CAGR（2024～2031年）

市場概要
血液および血液製剤
組み換えタンパク質
細胞・遺伝子治療製品
ワクチン

ウイルスクリアランス市場規模：エンドユーザー別 & CAGR（2024～2031年）

市場概要
製薬・バイオテクノロジー業界
学術調査機関
CRO

ウイルスクリアランス市場規模：地域別 & CAGR（2024～2031年）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021～2023年）

主要企業プロファイル

Charles River Laboratories
Merck KGaA
Texcell
WuXi AppTec
Sartorius AG
Eurofins Scientific
Vironova
Syngene International
Microbac Laboratories
Creative Biolabs
Nelson Labs
SGS AG
Lonza Group
Bioscience Laboratories
Labor Dr. Merk & Kollegen
Gilead Sciences
Poolbeg Pharma
Incyte
Genmab
Biogen

結論と推奨事項

Product Code: SQMIG35I2288

Global Viral Clearance Market size was valued at USD 492.9 billion in 2022 and is poised to grow from USD 572.26 billion in 2023 to USD 1889.07 billion by 2031, growing at a CAGR of 16.1% during the forecast period (2024-2031).

The viral clearance market is gaining traction due to the essential need for eliminating viral particles and TSE agents during the production of monoclonal antibodies, recombinant proteins, glycoproteins, and other biologics. As these products face risks from various contaminants, including viruses, bacteria, and fungi, robust viral safety practices are becoming imperative. Furthermore, the increasing investments in the pharmaceutical and biotechnology sectors, alongside a rising demand for vaccines and biotherapeutic agents, are propelling growth in this market. As manufacturers prioritize viral clearance to ensure product integrity and safety, the overall landscape of viral clearance processes is expected to evolve significantly in the coming years, highlighting the critical focus on compliance and efficacy in bioprocessing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Viral Clearance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Viral Clearance Market Segmental Analysis

Global Viral Clearance Market is segmented by method, application, end-user and region. Based on method, the market is segmented into viral removal method, viral inactivation method and viral detection method. Based on application, the market is segmented into blood and blood products, recombinant proteins, cellular & gene therapy products and vaccines. Based on end-user, the market is segmented into pharmaceutical and biotech industry, academic research institutes and cros. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Viral Clearance Market

The global viral clearance market is primarily driven by the increasing demand for biologics and vaccines, which significantly enhances market growth. Regulatory agencies place a high priority on ensuring viral safety, requiring comprehensive assessments and high-quality data for Investigational New Drug (IND) and Biologics License Application (BLA) approvals. This necessitates expertise in relevant processes and regulatory compliance, which not only facilitates strategic planning but also leads to potential savings in time, resources, and finances. Moreover, the rising prevalence of chronic viral infections and the urgent need for effective treatment options, coupled with increased investments in the life sciences sector and the development of innovative therapies, further fuel market expansion.

Restraints in the Global Viral Clearance Market

The Global Viral Clearance market faces several restraints that hinder its growth, notably the significant expenses and a shortage of skilled professionals in the field. The advanced technologies required for viral clearance studies come with high costs, which can deter investment and development. Additionally, the overall operational and procedural expenses related to viral safety add to these financial burdens, further constraining the market. The increasing demand for expertise combined with this skill gap only exacerbates these challenges, leading to higher costs and ultimately limiting the market's potential for growth and expansion in the evolving landscape of viral safety solutions.

Market Trends of the Global Viral Clearance Market

The Global Viral Clearance market is experiencing significant growth driven by an escalating demand for generics and biosimilars. As healthcare systems globally strive for cost-effective treatment options for chronic diseases, there is heightened investment in recombinant non-glycosylated proteins, which serve as a cornerstone for developing biosimilars. This trend is fueled by advancements in technology that enhance viral clearance processes, ensuring safety and efficacy. Furthermore, regulatory pressures and the increasing prevalence of chronic health conditions propel the market forward, making efficient viral clearance methodologies crucial for pharmaceutical and biopharmaceutical companies. Overall, these dynamics are shaping a robust and evolving landscape in the viral clearance sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement

Global Viral Clearance Market Size by Method & CAGR (2024-2031)

Market Overview
Viral Removal Method
- Chromatography
- Filtration
- Precipitation
Viral Inactivation Method
- Ph Modification
- Solvent Detergent (S/D)
- Pasteurization
- Dry Heat
- Others
Viral Detection Method
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- In Vivo Assay
- In Vitro Assay

Global Viral Clearance Market Size by Application & CAGR (2024-2031)

Market Overview
Blood and Blood Products
Recombinant Proteins
Cellular & Gene Therapy Products
Vaccines

Global Viral Clearance Market Size by End-User & CAGR (2024-2031)

Market Overview
Pharmaceutical and Biotech Industry
Academic Research Institutes
CROs

Global Viral Clearance Market Size & CAGR (2024-2031)

North America (Method, Application, End-User)
- USA
- Canada
Europe (Method, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Method, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Method, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Method, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Texcell
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vironova
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syngene International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microbac Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nelson Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioscience Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labor Dr. Merk & Kollegen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Poolbeg Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Incyte
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genmab
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments